Paramyxoviruses, Mumps Flashcards

1
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Paramyxoviridae

_________virus
______virus
_______virus

A

Paramyxovirus
Pneumovirus
Morbillivirus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Paramyxoviridae

Paramyxovirus - _________ , _________
Pneumovirus - _________ virus
Morbillivirus - _________

A

parainfluenza, mumps

respiratory syncytial virus

measles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Rubella virus is a member of the _____viridae!!!

A

Toga

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Structure: Paramyxoviridae
(Naked or Enveloped?) 150-300 nm
_______ , _________ symmetry
(SS or DS?) (DNA or RNA?) ,antisense monopartite

A

Enveloped

helical ; pleomorphic

SS ; RNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Viral Proteins- Paramyxoviridae

They all possess
______-directed ________________

 ______________ - parainfluenza and measles
 ____________ - parainfluenza

A

RNA-directed RNA polymerase

Hemagglutinin

Neuraminidase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Neuraminidase & hemagglutinin activities are (same or different?) sites of the (same or different ?) protein

A

different

same

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

_______ protein causes syncytia formation

A

Fusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Fusion protein causes ________ formation

A

syncytia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Parainfluenza Viruses

Paraflu:Clinical manifestions

mild or severe _________ of the ____________________________
particularly in (children or adults?)

A

infections

lower and upper respiratory tract

children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Paraflu: Classification
types ________ in humans

type ___ subtypes: ______

A

1,2,3,4

4

A & B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Paraflu: Epidemiology
occurs worldwide
usually endemic
primarily in _________________
reinfections is (common or rare?)

A

young children

Common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Paraflu: Diagnosis
clinical symptoms are (specific or nonspecific?)
_________ virus
Detect __________
Detect rise in ______________

A

nonspecific ; Isolate

viral antigens

specific antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Vaccine for parainfluenza is called??

A

No vaccine is available for Parainfluenza

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mumps virus

Mumps:Clinical manifestions
(localized or systemic?) ________ infection
children & young adults
________ of ________ glands( especially the ________ gland)

A

systemic ; febrile

swelling ; salivary glands

Parotid gland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mumps virus

________ is common
_______________ can occur
orchitis oophoritis occurs in (children or adults?)

A

meningitis

encephalitis

adults

17
Q

Single mumps serotype has shared antigens with ???

A

paraflu type 1

18
Q

Mumps:Pathogenesis
 infection by _________ leading to __________ that spreads to _______ and ________ causing _______ and cell death

A

droplet

viremia

glands ; nervous tissue

inflammation

19
Q

Mumps:Epidemiology

 worldwide
endemic in (urban or rural?) areas
intermittant in (urban or rural?) areas
epidemic 2-7 years
peak incidence Jan-May

A

urban

rural areas

20
Q

Mumps:Diagnosis

 TYPICAL is by _________ diagnosis

 ATYPICAL: ________ virus and viral antigen in ________ or ________. Detect specific Ig___ and Detect rising titer of Ig____

A

clinical

isolate

saliva : CSF

IgM ;of IgG

21
Q

Defenses against Mumps

 ________
__________ immunity
__________ immunity
lifelong protection

A

Interferon

humoral immunity

cell mediated immunity

22
Q

Mumps:Control
____________ vaccine
long term protection
reinfections (can or can not?) occur

A

live attentuated

Can

23
Q

Measles: Clinical manifestions

coryza, __________ , ______ rash ______________ rash ____ days later

A

conjunctivitis

fever rash

maculopapular

1-3

24
Q

Measles: Complications
________ , ______ , ________
SSPE (___________________________)-rare

A

otitis ; pneumonia

encephalitis

subacute sclerosing panencephalitis

25
Measles: Pathogenesis  ________ occurs multiples in cells of : _________ system, _________ system, ——— and _______
viremia lymphatic ; respiratory skin ; brain
26
Measles:Host Defenses  ————  ———— immunity  ———— immunity Life long protection
Interferon Humoral immunity Cell mediated immunity
27
Measles: Control Active vaccination ______________ virus vaccine long lasting protection Passive immunity measles _____________
Live attentuated virus hyperimmunoglobulin
28
WHO MeaslesVaccination Strategy "catch-up" everyone aged _______ years "keep-up" ____% of children at age _________ "follow-up" ____________
1-14 years 90% ; 12 months 3-5 years
29
RSV:Clinical manifestions _____________________ infection frequent in ________ significant in __________
upper & lower respiratory tract young children elderly
30
RSV: Pathogenesis  infection by __________ with ________ infects _________________ of respiratory mucosa  localized A___________ D__________ C___________
direct contact ; droplets ciliated epithelium Antibody Dependent Cytotoxicity
31
RSV: Host Defenses  _________ cell mediated immunity Humoral immunity ___________ immunity ( _______) reinfection possible
interferon Secretory immunity sIgA
32
RSV: Epidemiology  worldwide _________ climates epidemic winter and early spring infants & young children
temperate
33
RSV: Control _______ vaccine _________ as aerosol ___________ patients in hospitals
no ribavrin isolate
34